Life sciences stories
A stronger FY26 lifted Persistent's dividend to INR 40 a share as annual revenue climbed 17.4%, with quarterly growth extending to a 24th straight quarter.
Research teams could see faster target discovery as OpenAI opens GPT-Rosalind to qualified US customers for biology and drug discovery work.
Scientists without coding skills can now run AI-assisted drug design and wet-lab testing in one system, speeding early discovery.
A trust-backed board majority now gives Anthropic tighter oversight as it seeks to balance rapid AI growth with its public benefit mission.
The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.
Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.
Demand for AI market intelligence is driving AlphaSense to strengthen local leadership and multilingual coverage across EMEA and APAC.
Enterprises struggling with fragmented files and AI governance now get a new platform aimed at giving staff and agents safer access to data.
Private equity-backed businesses are adopting paid AI tools faster than the wider market, yet still lag venture-funded peers on full rollout.
Toronto will gain 27MW of new capacity in mid-2026 as Yondr enters Canada with a campus designed to curb water use and meet green standards.
The commitment could help Episode 1’s latest fund reach a first close and attract more private capital for early-stage UK start-ups.
The showcase highlighted early-stage ventures tackling clinical delays, relationship support and school safety as finalists pitched to investors and local firms.
The move gives UK life sciences firms a new source of scale-up capital as a funding gap has left many promising businesses short of backing.
The London biotech startup will use new funding to broaden deployments at major drugmakers, including Pfizer, and speed research decisions.
The investment firm is shifting towards regular portfolio realisations after two major sales, as Antonia Jenkinson takes over the finance brief.
The system is designed to protect dense technical spaces at two data halls while using less water and fitting tight mechanical layouts.
The funding will help expand Vancouver research, manufacturing and clinical trials, with hundreds of jobs and student co-op places expected to follow.
The shortlist spans the island and includes firms employing more than 3,000 people, as EY marks the 29th year of its award programme.
The deal will give Canberra access to AI risk findings and usage data as Anthropic expands research support and plans a Sydney office.
Canadian researchers and firms can now seek up to CAD $1 million per project as a new programme backs AI tools for drug discovery and trials.